The representatives of Organisation of Pharmaceutical Producers of India (OPPI), which represents multinational pharma companies and domestic pharma representatives that run PAP programmes, will meet minister of health and family Mansukh Mandaviya and officials from department of pharmaceutical (DoP), National Pharmaceutical Pricing Authority (NPPA) on Monday to discuss the issue regarding TMR on PAP drugs.
